SION - CIK 0002036042
The table below shows Sionna Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & equivalents | $63.32M | $50.83M | $40.98M | $82.69M |
| Short-term investments | - | - | - | - |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $220.96M | $252.33M | $266.75M | $273.68M |
| Property, plant & equipment | $2.07M | $2.14M | $2.25M | $2.39M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill |
| - |
| - |
| - |
| - |
| Total assets | $305.04M | $339.27M | $352.05M | $369.67M |
| Accounts payable | - | - | - | - |
| Total current liabilities | $9.78M | $9.85M | $7.55M | $9.53M |
| Long-term debt | - | - | - | - |
| Total liabilities | $16.83M | $17.60M | $15.62M | $17.91M |
| Retained earnings | -$283.13M | -$235.91M | -$215.64M | -$197.57M |
| Total equity | $288.21M | $321.67M | $336.43M | $351.77M |